143 related articles for article (PubMed ID: 2423784)
21. Hemodynamic effects of dibutyryl cyclic AMP in congestive heart failure.
Matsui S; Murakami E; Takekoshi N; Emoto J; Matoba M
Am J Cardiol; 1983 May; 51(8):1364-8. PubMed ID: 6303101
[TBL] [Abstract][Full Text] [Related]
22. A double-blind comparison of indoramin and propranolol in the treatment of moderate to severe essential hypertension.
Antani J; Buckle JW; Turner J; Cohen M
Curr Med Res Opin; 1983; 8(9):603-11. PubMed ID: 6365463
[TBL] [Abstract][Full Text] [Related]
23. Isosorbide dinitrate for the relief of severe heart failure after myocardial infarction.
Mantle JA; Russell RO; Moraski RE; Rackley CE
Am J Cardiol; 1976 Feb; 37(2):263-8. PubMed ID: 1108634
[TBL] [Abstract][Full Text] [Related]
24. Clinical use of sodium nitroprusside in chronic ischemic heart disease. Effects on peripheral vascular resistance and venous tone and on ventricular volume, pump and mechanical performance.
Miller RR; Vismara LA; Zelis R; Amsterdam EA; Mason DT
Circulation; 1975 Feb; 51(2):328-36. PubMed ID: 1112013
[TBL] [Abstract][Full Text] [Related]
25. Quantitative differences in the hemodynamic effects of captopril and nitroprusside in severe chronic heart failure.
Packer M; Meller J; Medina N; Yushak M
Am J Cardiol; 1983 Jan; 51(1):183-8. PubMed ID: 6336876
[TBL] [Abstract][Full Text] [Related]
26. Short-term hemodynamic effects of intravenous methyldopa in patients with congestive heart failure.
Manolis AS; Varriale P; Nobile J
Pharmacotherapy; 1987; 7(6):216-22. PubMed ID: 3444753
[TBL] [Abstract][Full Text] [Related]
27. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside.
Jaski BE; Fifer MA; Wright RF; Braunwald E; Colucci WS
J Clin Invest; 1985 Feb; 75(2):643-9. PubMed ID: 3973022
[TBL] [Abstract][Full Text] [Related]
28. Acute haemodynamic effects of urapidil in patients with chronic left ventricular failure.
Tebbe U; Wurst W; Neuhaus KL
Eur J Clin Pharmacol; 1988; 35(3):305-8. PubMed ID: 3181283
[TBL] [Abstract][Full Text] [Related]
29. Improvement of cardiac performance by intravenous infusion of L-arginine in patients with moderate congestive heart failure.
Koifman B; Wollman Y; Bogomolny N; Chernichowsky T; Finkelstein A; Peer G; Scherez J; Blum M; Laniado S; Iaina A
J Am Coll Cardiol; 1995 Nov; 26(5):1251-6. PubMed ID: 7594039
[TBL] [Abstract][Full Text] [Related]
30. The effects of intravenous carvedilol, a new multiple action vasodilatory beta-blocker, in congestive heart failure.
DasGupta P; Broadhurst P; Lahiri A
J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S12-6. PubMed ID: 1721973
[TBL] [Abstract][Full Text] [Related]
31. Beta blockade in congestive heart failure: persistent adverse haemodynamic effects during chronic treatment with subsequent doses.
Kukin ML; Kalman J; Mannino MM; Buchholz-Varley C; Ocampo O
Heart; 1997 Nov; 78(5):444-9. PubMed ID: 9415001
[TBL] [Abstract][Full Text] [Related]
32. Comparative hemodynamic effects of intravenous dobutamine and MDL-17,043, a new cardioactive drug, in severe congestive heart failure.
Amin DK; Shah PK; Shellock FG; Hulse S; Brandon G; Spangenberg R; Swan HJ
Am Heart J; 1985 Jan; 109(1):91-8. PubMed ID: 3155585
[TBL] [Abstract][Full Text] [Related]
33. Separation of the direct myocardial and vasodilator actions of milrinone administered by an intracoronary infusion technique.
Ludmer PL; Wright RF; Arnold JM; Ganz P; Braunwald E; Colucci WS
Circulation; 1986 Jan; 73(1):130-7. PubMed ID: 3940664
[TBL] [Abstract][Full Text] [Related]
34. Hemodynamic differences between supine and upright exercise in patients with congestive heart failure.
Kramer B; Massie B; Topic N
Circulation; 1982 Oct; 66(4):820-5. PubMed ID: 7116598
[TBL] [Abstract][Full Text] [Related]
35. Clinical cardiac electrophysiological assessment of indoramin.
Butrous GS; Camm AJ
J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S137-43. PubMed ID: 2423787
[TBL] [Abstract][Full Text] [Related]
36. Effects of amrinone on myocardial energy metabolism and hemodynamics in patients with severe congestive heart failure due to coronary artery disease.
Benotti JR; Grossman W; Braunwald E; Carabello BA
Circulation; 1980 Jul; 62(1):28-34. PubMed ID: 7379283
[TBL] [Abstract][Full Text] [Related]
37. Hemodynamic action of nicorandil in chronic congestive heart failure.
Solal AC; Jaeger P; Bouthier J; Juliard JM; Dahan M; Gourgon R
Am J Cardiol; 1989 Jun; 63(21):44J-48J. PubMed ID: 2525325
[TBL] [Abstract][Full Text] [Related]
38. Intravenous and oral MDL 17043 (a new inotrope-vasodilator agent) in congestive heart failure: hemodynamic and clinical evaluation in 38 patients.
Kereiakes D; Chatterjee K; Parmley WW; Atherton B; Curran D; Kereiakes A; Spangenberg R
J Am Coll Cardiol; 1984 Nov; 4(5):884-9. PubMed ID: 6238076
[TBL] [Abstract][Full Text] [Related]
39. Acute and chronic effects of nicardipine on systolic and diastolic left ventricular performance in patients with heart failure: a pilot study.
Lahiri A; Robinson CW; Kohli RS; Caruana MP; Raftery EB
Clin Cardiol; 1986 Jun; 9(6):257-61. PubMed ID: 3720049
[TBL] [Abstract][Full Text] [Related]
40. Central and renal hemodynamic effects of a new agonist at peripheral dopamine- and beta-2 adrenoreceptors (dopexamine) in patients with heart failure.
Jamison M; Widerhorn J; Weber L; Campese V; Vasquez J; Hovanessian L; Rahimtoola SH; Elkayam U
Am Heart J; 1989 Mar; 117(3):607-14. PubMed ID: 2537556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
